The A to Z of modulated cell patterning by mammalian thioredoxin reductases

Free Radical Biology and Medicine

Volumn 115, Issue , 2018, Pages 484-496

  Dagnell, Markus ^a   Schmidt, Edward E ^b   Arnér, Elias S J ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b MONTANA STATE UNIVERSITY   (United States)

Author keywords

Cell patterning; Redox signaling; Thioredoxin; Thioredoxin reductase

Indexed keywords

GLUTATHIONE; GLYCOGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; MAMMALIAN TARGET OF RAPAMYCIN; METHIONINE SULFOXIDE REDUCTASE A; METHIONINE SULFOXIDE REDUCTASE B; METHIONINE SULFOXIDE REDUCTASE B1; PEROXIREDOXIN 3; PROTEIN P53; RIBONUCLEOTIDE REDUCTASE; STAT3 PROTEIN; THIOREDOXIN REDUCTASE 1; THIOREDOXIN REDUCTASE 2; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; ANGIOGENESIS MODULATOR; PRR13 PROTEIN, HUMAN; REPRESSOR PROTEIN; THIOREDOXIN REDUCTASE; TXNRD2 PROTEIN, HUMAN;

ADIPOGENESIS; BIOACCUMULATION; CANCER PROGNOSIS; CELL COMPARTMENTALIZATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL PATTERNING; CELL PROLIFERATION; CELL VIABILITY; CELLULAR STRESS RESPONSE; DOWN REGULATION; DROSOPHILA MELANOGASTER; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; GLUTATHIONE METABOLISM; IN VITRO STUDY; NITROSYLATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; CYTOSOL; HUMAN; MAMMAL; METABOLISM; MITOCHONDRION;

ANGIOGENESIS MODULATING AGENTS; ANIMALS; CYTOSOL; HUMANS; MAMMALS; MITOCHONDRIA; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; THIOREDOXIN REDUCTASE 2; THIOREDOXIN-DISULFIDE REDUCTASE;

EID: 85039846564     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2017.12.029     Document Type: Review

References (221)

1. Rhee, S.G., Cell signaling. H2O2, a necessary evil for cell signaling. Science 312:5782 (2006), 1882–1883.
2. Eriksson, S., Prigge, J.R., Talago, E.A., Arner, E.S., Schmidt, E.E., Dietary methionine can sustain cytosolic redox homeostasis in the mouse liver. Nat. Commun., 6, 2015, 6479.
3. Deponte, M., Glutathione catalysis and the reaction mechanisms of glutathione-dependent enzymes. Biochim. Biophys. Acta 1830:5 (2013), 3217–3266.
4. Brigelius-Flohe, R., Flohe, L., Basic principles and emerging concepts in the redox control of transcription factors. Antioxid. Redox Signal. 15:8 (2011), 2335–2381.
5. Toppo, S., Flohe, L., Ursini, F., Vanin, S., Maiorino, M., Catalytic mechanisms and specificities of glutathione peroxidases: variations of a basic scheme. Biochim. Biophys. Acta 1790:11 (2009), 1486–1500.
6. Lillig, C.H., Berndt, C., Holmgren, A., Glutaredoxin systems. Biochim. Biophys. Acta 1780:11 (2008), 1304–1317.
7. Fernandes, A.P., Holmgren, A., Glutaredoxins: glutathione-dependent redox enzymes with functions far beyond a simple thioredoxin backup system. Antioxid. Redox Signal. 6:1 (2004), 63–74.
8. Lei, X.G., Zhu, J.H., Cheng, W.H., Bao, Y., Ho, Y.S., Reddi, A.R., Holmgren, A., Arner, E.S., Paradoxical roles of antioxidant enzymes: basic mechanisms and health implications. Physiol. Rev. 96:1 (2016), 307–364.
9. Ye, Z.W., Zhang, J., Townsend, D.M., Tew, K.D., Oxidative stress, redox regulation and diseases of cellular differentiation. Biochim. Biophys. Acta 1850:8 (2015), 1607–1621.
10. Cebula, M., Schmidt, E.E., Arner, E.S., TrxR1 as a potent regulator of the Nrf2-Keap1 response system. Antioxid. Redox Signal. 23:10 (2015), 823–853.
11. Groitl, B., Jakob, U., Thiol-based redox switches. Biochim. Biophys. Acta 1844:8 (2014), 1335–1343.
12. Sengupta, R., Holmgren, A., Thioredoxin and thioredoxin reductase in relation to reversible S-nitrosylation. Antioxid. Redox Signal. 18:3 (2013), 259–269.
13. Kesarwani, P., Murali, A.K., Al-Khami, A.A., Mehrotra, S., Redox regulation of T-cell function: from molecular mechanisms to significance in human health and disease. Antioxid. Redox Signal. 18:12 (2013), 1497–1534.
14. Arnér, E.S.J., Focus on mammalian thioredoxin reductases – Important selenoproteins with versatile functions. Biochim. Biophys. Acta 1790:6 (2009), 495–526.
15. Winterbourn, C.C., Hampton, M.B., Thiol chemistry and specificity in redox signaling. Free Radic. Biol. Med. 45:5 (2008), 549–561.
16. Matsuzawa, A., Ichijo, H., Redox control of cell fate by MAP kinase: physiological roles of ASK1-MAP kinase pathway in stress signaling. Biochim. Biophys. Acta 1780:11 (2008), 1325–1336.
17. Lillig, C.H., Holmgren, A., Thioredoxin and related molecules-from biology to health and disease. Antioxid. Redox Signal. 9:1 (2007), 25–47.
18. Rhee, S.G., Chae, H.Z., Kim, K., Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic. Biol. Med. 38:12 (2005), 1543–1552.
19. Rundlöf, A.-K., Arnér, E.S.J., Regulation of the mammalian selenoprotein thioredoxin reductase 1 in relation to cellular phenotype, growth and signaling events. Antioxid. Redox Signal. 6 (2004), 41–52.
20. Nordberg, J., Arnér, E.S.J., Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic. Biol. Med. 31 (2001), 1287–1312.
21. Rogers, L.K., Tamura, T., Rogers, B.J., Welty, S.E., Hansen, T.N., Smith, C.V., Analyses of glutathione reductase hypomorphic mice indicate a genetic knockout. Toxicol. Sci. 82:2 (2004), 367–373.
22. Rogers, L.K., Bates, C.M., Welty, S.E., Smith, C.V., Diquat induces renal proximal tubule injury in glutathione reductase-deficient mice. Toxicol. Appl. Pharmacol. 217:3 (2006), 289–298.
23. Prigge, J.R., Coppo, L., Martin, S.S., Ogata, F., Miller, C.G., Bruschwein, M.D., Orlicky, D.J., Shearn, C.T., Kundert, J.A., Lytchier, J., Herr, A.E., Mattsson, A., Taylor, M.P., Gustafsson, T.N., Arner, E.S.J., Holmgren, A., Schmidt, E.E., Hepatocyte hyperproliferation upon liver-specific co-disruption of thioredoxin-1, thioredoxin reductase-1, and glutathione reductase. Cell Rep. 19:13 (2017), 2771–2781.
24. Griffith, O.W., Meister, A., Glutathione: interorgan translocation, turnover, and metabolism. Proc. Natl. Acad. Sci. USA 76:11 (1979), 5606–5610.
25. Griffith, O.W., Meister, A., Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). J. Biol. Chem. 254:16 (1979), 7558–7560.
26. Griffith, O.W., Meister, A., Origin and turnover of mitochondrial glutathione. Proc. Natl. Acad. Sci. USA 82:14 (1985), 4668–4672.
27. Meister, A., New aspects of glutathione biochemistry and transport–selective alteration of glutathione metabolism. Nutr. Rev. 42:12 (1984), 397–410.
28. Meister, A., Griffith, O.W., Novogrodsky, A., Tate, S.S., New aspects of glutathione metabolism and translocation in mammals. Ciba Found. Symp. 72 (1979), 135–161.
29. Jakupoglu, C., Przemeck, G.K., Schneider, M., Moreno, S.G., Mayr, N., Hatzopoulos, A.K., de Angelis, M.H., Wurst, W., Bornkamm, G.W., Brielmeier, M., Conrad, M., Cytoplasmic thioredoxin reductase is essential for embryogenesis but dispensable for cardiac development. Mol. Cell Biol. 25:5 (2005), 1980–1988.
30. Matsui, M., Oshima, M., Oshima, H., Takaku, K., Maruyama, T., Yodoi, J., Taketo, M.M., Early embryonic lethality caused by targeted disruption of the mouse thioredoxin gene. Dev. Biol. 178:1 (1996), 179–185.
31. Nonn, L., Williams, R.R., Erickson, R.P., Powis, G., The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous mice. Mol. Cell Biol. 23:3 (2003), 916–922.
32. Conrad, M., Transgenic mouse models for the vital selenoenzymes cytosolic thioredoxin reductase, mitochondrial thioredoxin reductase and glutathione peroxidase 4. Biochim. Biophys. Acta 1790:11 (2009), 1575–1585.
33. Bondareva, A.A., Capecchi, M.R., Iverson, S.V., Li, Y., Lopez, N.I., Lucas, O., Merrill, G.F., Prigge, J.R., Siders, A.M., Wakamiya, M., Wallin, S.L., Schmidt, E.E., Effects of thioredoxin reductase-1 deletion on embryogenesis and transcriptome. Free Radic. Biol. Med. 43:6 (2007), 911–923.
34. Postic, C., Shiota, M., Niswender, K.D., Jetton, T.L., Chen, Y., Moates, J.M., Shelton, K.D., Lindner, J., Cherrington, A.D., Magnuson, M.A., Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J. Biol. Chem. 274:1 (1999), 305–315.
35. Weisend, C.M., Kundert, J.A., Suvorova, E.S., Prigge, J.R., Schmidt, E.E., Cre activity in fetal albCre mouse hepatocytes: utility for developmental studies. Genesis 47:12 (2009), 789–792.
36. Suvorova, E.S., Lucas, O., Weisend, C.M., Rollins, M.F., Merrill, G.F., Capecchi, M.R., Schmidt, E.E., Cytoprotective Nrf2 pathway is induced in chronically txnrd 1-deficient hepatocytes. PLoS One, 4(7), 2009, e6158.
37. Peng, X., Gimenez-Cassina, A., Petrus, P., Conrad, M., Ryden, M., Arner, E.S., Thioredoxin reductase 1 suppresses adipocyte differentiation and insulin responsiveness. Sci. Rep., 6, 2016, 28080.
38. Peng, X., Mandal, P.K., Kaminskyy, V.O., Lindqvist, A., Conrad, M., Arner, E.S., Sec-containing TrxR1 is essential for self-sufficiency of cells by control of glucose-derived H2O2. Cell Death Dis., 5, 2014, e1235.
39. Prigge, J.R., Eriksson, S., Iverson, S.V., Meade, T.A., Capecchi, M.R., Arner, E.S., Schmidt, E.E., Hepatocyte DNA replication in growing liver requires either glutathione or a single allele oftxnrd1. Free Radic. Biol. Med. 52:4 (2012), 803–810.
40. Rollins, M.F., van der Heide, D.M., Weisend, C.M., Kundert, J.A., Comstock, K.M., Suvorova, E.S., Capecchi, M.R., Merrill, G.F., Schmidt, E.E., Hepatocytes lacking thioredoxin reductase 1 have normal replicative potential during development and regeneration. J. Cell Sci. 123:Pt 14 (2010), 2402–2412.
41. Iverson, S.V., Eriksson, S., Xu, J., Prigge, J.R., Talago, E.A., Meade, T.A., Meade, E.S., Capecchi, M.R., Arner, E.S., Schmidt, E.E., Txnrd1-dependent, A., metabolic switch alters hepatic lipogenesis, glycogen storage, and detoxification. Free Radic. Biol. Med. 63 (2013), 369–380.
42. Locy, M.L., Rogers, L.K., Prigge, J.R., Schmidt, E.E., Arner, E.S., Tipple, T.E., Thioredoxin reductase inhibition elicits Nrf2-mediated responses in Clara cells: implications for oxidant-induced lung injury. Antioxid. Redox Signal. 17:10 (2012), 1407–1416.
43. Schmidt, E.E., Interplay between cytosolic disulfide reductase systems and the Nrf2/Keap1 pathway. Biochem. Soc. Trans. 43:4 (2015), 632–638.
44. Su, D., Gladyshev, V.N., Alternative splicing involving the thioredoxin reductase module in mammals: a glutaredoxin-containing thioredoxin reductase 1. Biochemistry 43:38 (2004), 12177–12188.
45. Rundlof, A.K., Janard, M., Miranda-Vizuete, A., Arner, E.S., Evidence for intriguingly complex transcription of human thioredoxin reductase 1. Free Radic. Biol. Med. 36:5 (2004), 641–656.
46. Damdimopoulos, A.E., Miranda-Vizuete, A., Treuter, E., Gustafsson, J.Å., Spyrou, G., An alternative splicing variant of the selenoprotein thioredoxin reductase is a modulator of estrogen signaling. J. Biol. Chem. 279:37 (2004), 38721–38729.
47. Sun, Q.A., Zappacosta, F., Factor, V.M., Wirth, P.J., Hatfield, D.L., Gladyshev, V.N., Heterogeneity within animal thioredoxin reductases. Evidence for alternative first exon splicing. J. Biol. Chem. 276 (2001), 3106–3114.
48. Cebula, M., Moolla, N., Capovilla, A., Arner, E.S., The rare TXNRD1_v3 (“v3”) splice variant of human thioredoxin reductase 1 protein is targeted to membrane rafts by N-acylation and induces filopodia independently of its redox active site integrity. J. Biol. Chem. 288:14 (2013), 10002–10011.
49. Damdimopoulou, P.E., Miranda-Vizuete, A., Arner, E.S., Gustafsson, J.A., Damdimopoulos, A.E., The human thioredoxin reductase-1 splice variant TXNRD1_v3 is an atypical inducer of cytoplasmic filaments and cell membrane filopodia. Biochim. Biophys. Acta 1793:10 (2009), 1588–1596.
50. Dammeyer, P., Damdimopoulos, A.E., Nordman, T., Jimenez, A., Miranda-Vizuete, A., Arner, E.S., Induction of cell membrane protrusions by the N-terminal glutaredoxin domain of a rare splice variant of human thioredoxin reductase 1. J. Biol. Chem. 283:5 (2008), 2814–2821.
51. Gromer, S., Urig, S., Becker, K., The thioredoxin system–from science to clinic. Med. Res. Rev. 24:1 (2004), 40–89.
52. Nordberg, J., Arner, E.S., Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic. Biol. Med. 31:11 (2001), 1287–1312.
53. Nishiyama, A., Masutani, H., Nakamura, H., Nishinaka, Y., Yodoi, J., Redox regulation by thioredoxin and thioredoxin-binding proteins. IUBMB Life 52:1–2 (2001), 29–33.
54. Nishinaka, Y., Masutani, H., Nakamura, H., Yodoi, J., Regulatory roles of thioredoxin in oxidative stress-induced cellular responses. Redox Rep. 6:5 (2001), 289–295.
55. Arner, E.S., Holmgren, A., Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 267:20 (2000), 6102–6109.
56. Doka, E., Pader, I., Biro, A., Johansson, K., Cheng, Q., Ballago, K., Prigge, J.R., Pastor-Flores, D., Dick, T.P., Schmidt, E.E., Arner, E.S.J., Nagy, P., A novel persulfide detection method reveals protein persulfide- and polysulfide-reducing functions of thioredoxin and glutathione systems. Sci. Adv., 2(1), 2016 (e1500968-e1500968).
57. Pader, I., Sengupta, R., Cebula, M., Xu, J., Lundberg, J.O., Holmgren, A., Johansson, K., Arner, E.S., Thioredoxin-related protein of 14 kDa is an efficient L-cystine reductase and S-denitrosylase. Proc. Natl. Acad. Sci. USA 111:19 (2014), 6964–6969.
58. Dagnell, M., Frijhoff, J., Pader, I., Augsten, M., Boivin, B., Xu, J., Mandal, P.K., Tonks, N.K., Hellberg, C., Conrad, M., Arner, E.S., Ostman, A., Selective activation of oxidized PTP1B by the thioredoxin system modulates PDGF-beta receptor tyrosine kinase signaling. Proc. Natl. Acad. Sci. USA 110:33 (2013), 13398–13403.
59. Woo, J.R., Kim, S.J., Jeong, W., Cho, Y.H., Lee, S.C., Chung, Y.J., Rhee, S.G., Ryu, S.E., Structural basis of cellular redox regulation by human TRP14. J. Biol. Chem. 279:46 (2004), 48120–48125.
60. Jeong, W., Yoon, H.W., Lee, S.R., Rhee, S.G., Identification and characterization of TRP14, a thioredoxin-related protein of 14 kDa. New insights into the specificity of thioredoxin function. J. Biol. Chem. 279:5 (2004), 3142–3150.
61. Jeong, W., Chang, T.S., Boja, E.S., Fales, H.M., Rhee, S.G., Roles of TRP14, a thioredoxin-related protein in tumor necrosis factor-alpha signaling pathways. J. Biol. Chem. 279:5 (2004), 3151–3159.
62. Prigge, J.R., Eriksson, S., Iverson, S.V., Meade, T.A., Capecchi, M.R., Arnér, E.S.J., Schmidt, E.E., Hepatocyte DNA replication in growing liver requires either glutathione or a single allele oftxnrd1. Free Radic. Biol. Med. 52 (2012), 803–810.
63. Luthman, M., Eriksson, S., Holmgren, A., Thelander, L., Glutathione-dependent hydrogen donor system for calf thymus ribonucleoside-diphosphate reductase. Proc. Natl. Acad. Sci. USA 76:5 (1979), 2158–2162.
64. Zahedi Avval, F., Holmgren, A., Molecular mechanisms of thioredoxin and glutaredoxin as hydrogen donors for Mammalian s phase ribonucleotide reductase. J. Biol. Chem. 284:13 (2009), 8233–8240.
65. Nordlund, P., Reichard, P., Ribonucleotide reductases. Annu. Rev. Biochem. 75 (2006), 681–706.
66. Holmgren, A., Hydrogen donor system for Escherichia coli ribonucleoside-diphosphate reductase dependent upon glutathione. Proc. Natl. Acad. Sci. USA 73:7 (1976), 2275–2279.
67. Holmgren, A., Glutathione-dependent synthesis of deoxyribonucleotides. Purification and characterization of glutaredoxin from Escherichia coli. J. Biol. Chem. 254:9 (1979), 3664–3671.
68. Hudemann, C., Lonn, M.E., Godoy, J.R., Avval, F.Z., Capani, F., Holmgren, A., Lillig, C.H., Identification, expression pattern, and characterization of mouse glutaredoxin 2 isoforms. Antioxid. Redox Signal., 2008.
69. Hudemann, C., Lonn, M.E., Godoy, J.R., Zahedi Avval, F., Capani, F., Holmgren, A., Lillig, C.H., Identification, expression pattern, and characterization of mouse glutaredoxin 2 isoforms. Antioxid. Redox Signal. 11:1 (2009), 1–14.
70. Johansson, C., Lillig, C.H., Holmgren, A., Human mitochondrial glutaredoxin reduces S-glutathionylated proteins with high affinity accepting electrons from either glutathione or thioredoxin reductase. J. Biol. Chem. 279:9 (2004), 7537–7543.
71. Hansson, H.-A., Holmgren, A., Rozell, B., Stemme, S., Localization of thioredoxin, thioredoxin reductase and ribonucleotide reductase in cells: immunohistochemical aspects. Holmgren, A., et al. (eds.) Thioredoxin and Glutaredoxin Systems: Structure and Function, 1986, Raven Press, New York, 177–187.
72. Hansson, H.A., Rozell, B., Stemme, S., Engstr:om, Y., Thelander, L., Holmgren, A., Different cellular distribution of thioredoxin and subunit M1 of ribonucleotide reductase in rat tissues. Exp. Cell Res. 163 (1986), 363–369.
73. Hansson, H.-A., Holmgren, A., Norstedt, G., Rozell, B., Changes in the distribution of insulin-like growth factor I, thioredoxin, thioredoxin reductase and ribonucleotide reductase during the development of the retina. Exp. Eye Res. 48 (1989), 411–420.
74. Brown, K.K., Eriksson, S.E., Arner, E.S., Hampton, M.B., Mitochondrial peroxiredoxin 3 is rapidly oxidized in cells treated with isothiocyanates. Free Radic. Biol. Med. 45:4 (2008), 494–502.
75. Cox, A.G., Brown, K.K., Arner, E.S., Hampton, M.B., The thioredoxin reductase inhibitor auranofin triggers apoptosis through a Bax/Bak-dependent process that involves peroxiredoxin 3 oxidation. Biochem. Pharmacol., 2008.
76. Fernando, M.R., Lechner, J.M., Lofgren, S., Gladyshev, V.N., Lou, M.F., Mitochondrial thioltransferase (glutaredoxin 2) has GSH-dependent and thioredoxin reductase-dependent peroxidase activities in vitro and in lens epithelial cells. FASEB J. 20:14 (2006), 2645–2647.
77. Noh, Y.H., Baek, J.Y., Jeong, W., Rhee, S.G., Chang, T.S., Sulfiredoxin translocation into mitochondria plays a crucial role in reducing hyperoxidized peroxiredoxin III. J. Biol. Chem. 284:13 (2009), 8470–8477.
78. Rhee, S.G., Kil, I.S., Mitochondrial H2O2 signaling is controlled by the concerted action of peroxiredoxin III and sulfiredoxin: linking mitochondrial function to circadian rhythm. Free Radic. Biol. Med. 100 (2016), 73–80.
79. Kil, I.S., Ryu, K.W., Lee, S.K., Kim, J.Y., Chu, S.Y., Kim, J.H., Park, S., Rhee, S.G., Circadian oscillation of sulfiredoxin in the mitochondria. Mol. Cell 59:4 (2015), 651–663.
80. Kil, I.S., Lee, S.K., Ryu, K.W., Woo, H.A., Hu, M.C., Bae, S.H., Rhee, S.G., Feedback control of adrenal steroidogenesis via H2O2-dependent, reversible inactivation of peroxiredoxin III in mitochondria. Mol. Cell 46:5 (2012), 584–594.
81. Huang, Y., Ainsley, J.A., Reijmers, L.G., Jackson, F.R., Translational profiling of clock cells reveals circadianly synchronized protein synthesis. PLoS Biol., 11(11), 2013, e1001703.
82. Barajas-Lopez Jde, D., Serrato, A.J., Cazalis, R., Meyer, Y., Chueca, A., Reichheld, J.P., Sahrawy, M., Circadian regulation of chloroplastic f and m thioredoxins through control of the CCA1 transcription factor. J. Exp. Bot. 62:6 (2011), 2039–2051.
83. Oien, D.B., Moskovitz, J., Substrates of the methionine sulfoxide reductase system and their physiological relevance. Curr. Top. Dev. Biol. 80 (2008), 93–133.
84. Kim, H.Y., Gladyshev, V.N., Methionine sulfoxide reductases: selenoprotein forms and roles in antioxidant protein repair in mammals. Biochem. J. 407:3 (2007), 321–329.
85. Lee, B.C., Peterfi, Z., Hoffmann, F.W., Moore, R.E., Kaya, A., Avanesov, A., Tarrago, L., Zhou, Y., Weerapana, E., Fomenko, D.E., Hoffmann, P.R., Gladyshev, V.N., MsrB1 and MICALs regulate actin assembly and macrophage function via reversible stereoselective methionine oxidation. Mol. Cell 51:3 (2013), 397–404.
86. Vinokur, V., Grinberg, L., Berenshtein, E., Gross, M., Moskovitz, J., Reznick, A.Z., Chevion, M., Eliashar, R., Methionine-centered redox cycle in organs of the aero-digestive tract of young and old rats. Biogerontology, 2008.
87. Moskovitz, J., Bar-Noy, S., Williams, W.M., Requena, J., Berlett, B.S., Stadtman, E.R., Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proc. Natl. Acad. Sci. USA 98 (2001), 12920–12925.
88. Moskovitz, J., Prolonged selenium-deficient diet in MsrA knockout mice causes enhanced oxidative modification to proteins and affects the levels of antioxidant enzymes in a tissue-specific manner. Free Radic. Res. 41:2 (2007), 162–171.
89. Fixsen, S.M., Howard, M.T., Processive selenocysteine incorporation during synthesis of eukaryotic selenoproteins. J. Mol. Biol. 399:3 (2010), 385–396.
90. Stoytcheva, Z., Tujebajeva, R.M., Harney, J.W., Berry, M.J., Efficient incorporation of multiple selenocysteines involves an inefficient decoding step serving as a potential translational checkpoint and ribosome bottleneck. Mol. Cell Biol. 26:24 (2006), 9177–9184.
91. Xu, J., Cheng, Q., Arner, E.S., Details in the catalytic mechanism of mammalian thioredoxin reductase 1 revealed using point mutations and juglone-coupled enzyme activities. Free Radic. Biol. Med. 94 (2016), 110–120.
92. Xu, J., Eriksson, S.E., Cebula, M., Sandalova, T., Hedstrom, E., Pader, I., Cheng, Q., Myers, C.R., Antholine, W.E., Nagy, P., Hellman, U., Selivanova, G., Lindqvist, Y., Arner, E.S., The conserved Trp114 residue of thioredoxin reductase 1 has a redox sensor-like function triggering oligomerization and crosslinking upon oxidative stress related to cell death. Cell Death Dis., 6, 2015, e1616.
93. Cheng, Q., Antholine, W.E., Myers, J.M., Kalyanaraman, B., Arnér, E.S.J., Myers, C.R., The selenium-independent inherent pro-oxidant NADPH oxidase activity of mammalian thioredoxin reductase and its selenium-dependent direct peroxidase activities. J. Biol. Chem. 285:28 (2010), 21708–21723.
94. Anestål, K., Prast-Nielsen, S., Cenas, N., Arnér, E.S.J., Cell death by SecTRAPs – thioredoxin reductase as a prooxidant killer of cells. PLoS One, 3(4), 2008, e1846.
95. Arner, E.S.J., Selenium compromised thioredoxin reductase-derived apoptotic proteins (SecTRAPs): potent killers of cancer cells. Free Radic. Res., 40, 2006 (S51-S51).
96. Rundlöf, A.-K., Carlsten, M., Arnér, E.S.J., The core promoter of human thioredoxin reductase 1: cloning, transcriptional activity and Oct-1, Sp1 and Sp3 binding reveal a housekeeping-type promoter for the ARE-regulated gene. J. Biol. Chem. 276 (2001), 30542–30551.
97. Hintze, K.J., Wald, K.A., Zeng, H., Jeffery, E.H., Finley, J.W., Thioredoxin reductase in human hepatoma cells is transcriptionally regulated by sulforaphane and other electrophiles via an antioxidant response element. J. Nutr. 133:9 (2003), 2721–2727.
98. Leone, A., Roca, M.S., Ciardiello, C., Costantini, S., Budillon, A., Oxidative stress gene expression profile correlates with cancer patient poor prognosis: identification of crucial pathways might select novel therapeutic approaches. Oxid. Med. Cell. Longev., 2017, 2017, 18.
99. Bhatia, M., McGrath, K.L., Di Trapani, G., Charoentong, P., Shah, F., King, M.M., Clarke, F.M., Tonissen, K.F., The thioredoxin system in breast cancer cell invasion and migration. Redox Biol. 8 (2016), 68–78.
100. Cadenas, C., Franckenstein, D., Schmidt, M., Gehrmann, M., Hermes, M., Geppert, B., Schormann, W., Maccoux, L.J., Schug, M., Schumann, A., Wilhelm, C., Freis, E., Ickstadt, K., Rahnenfuhrer, J., Baumbach, J.I., Sickmann, A., Hengstler, J.G., Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer. Breast Cancer Res., 12(3), 2010, R44.
101. Dammeyer, P., Damdimopoulos, A., Nordman, T., Jimenez, A., Miranda-Vizuete, A., Arnér, E.S.J., Induction of cell membrane protrusions by the N-terminal glutaredoxin domain of a rare splice variant of human thioredoxin reductase 1. J. Biol. Chem. 283:5 (2007), 2814–2821.
102. Osborne, S.A., Tonissen, K.F., Genomic organisation and alternative splicing of mouse and human thioredoxin reductase 1 genes. BMC Genom., 2(1), 2001, 10.
103. Cebula, M., Moolla, N., Capovilla, A., Arner, E.S.J., The rare TXNRD1_v3 (“v3”) splice variant of human thioredoxin reductase 1 protein Is targeted to membrane rafts by N-acylation and induces filopodia independently of its redox active site integrity. J. Biol. Chem. 288:14 (2013), 10002–10011.
104. Damdimopoulou, P.E., Miranda-Vizuete, A., Arner, E.S.J., Gustafsson, J.-A., Damdimopoulos, A.E., The human thioredoxin reductase-1 splice variant TXNRD1_v3 is an atypical inducer of cytoplasmic filaments and cell membrane filopodia. Biochim. Biophys. Acta Mol. Cell Res. 1793:10 (2009), 1588–1596.
105. Rajalin, A.M., Micoogullari, M., Sies, H., Steinbrenner, H., Upregulation of the thioredoxin-dependent redox system during differentiation of 3T3-L1 cells to adipocytes. Biol. Chem. 395:6 (2014), 667–677.
106. Pickering, A.M., Lehr, M., Gendron, C.M., Pletcher, S.D., Miller, R.A., Mitochondrial thioredoxin reductase 2 is elevated in long-lived primate as well as rodent species and extends fly mean lifespan. Aging Cell 16:4 (2017), 683–692.
107. Mercatelli, N., Fittipaldi, S., De Paola, E., Dimauro, I., Paronetto, M.P., Jackson, M.J., Caporossi, D., MiR-23-TrxR1 as a novel molecular axis in skeletal muscle differentiation. Sci. Rep., 7(1), 2017, 7219.
108. Fernandes, A.P., Capitanio, A., Selenius, M., Brodin, O., Rundlof, A.K., Bjornstedt, M., Expression profiles of thioredoxin family proteins in human lung cancer tissue: correlation with proliferation and differentiation. Histopathology 55:3 (2009), 313–320.
109. Kudin, A.P., Baron, G., Zsurka, G., Hampel, K.G., Elger, C.E., Grote, A., Weber, Y., Lerche, H., Thiele, H., Nuernberg, P., Schulz, H., Ruppert, A.-K., Sander, T., Cheng, Q., Arner, E.S.J., Schomburg, L., Seeher, S., Fradejas-Villar, N., Schweizer, U., Kunz, W.S., Homozygous mutation in TXNRD1 is associated with genetic generalized epilepsy. Free Radic. Biol. Med. 106 (2017), 270–277.
110. Sibbing, D., Pfeufer, A., Perisic, T., Mannes, A.M., Fritz-Wolf, K., Unwin, S., Sinner, M.F., Gieger, C., Gloeckner, C.J., Wichmann, H.E., Kremmer, E., Schafer, Z., Walch, A., Hinterseer, M., Nabauer, M., Kaab, S., Kastrati, A., Schomig, A., Meitinger, T., Bornkamm, G.W., Conrad, M., von Beckerath, N., Mutations in the mitochondrial thioredoxin reductase gene TXNRD2 cause dilated cardiomyopathy. Eur. Heart J. 32:9 (2011), 1121–1133.
111. Prigge, J.R., Coppo, L., Martin, S.S., Ogata, F., Miller, C.G., Bruschwein, M.D., Orlicky, D.J., Shearn, C.T., Kundert, J.A., Lytchier, J., Herr, A.E., Mattsson, A., Taylor, M.P., Gustafsson, T.N., Arner, E.S.J., Holmgren, A., Schmidt, E.E., Hepatocyte hyperproliferation upon liver-specific co-disruption of thioredoxin-1, thioredoxin reductase-1, and glutathione reductase. Cell Rep. 19:13 (2017), 2771–2781.
112. Eriksson, S., Prigge, J.R., Talago, E.A., Arner, E.S.J., Schmidt, E.E., Dietary methionine can sustain cytosolic redox homeostasis in the mouse liver. Nat. Commun., 6, 2015.
113. Iverson, S.V., Eriksson, S., Xu, J., Prigge, J.R., Talago, E.A., Meade, T.A., Meade, E.S., Capecchi, M.R., Arner, E.S.J., Schmidt, E.E., A Txnrd1-dependent metabolic switch alters hepatic lipogenesis, glycogen storage, and detoxification. Free Radic. Biol. Med. 63 (2013), 369–380.
114. Soerensen, J., Jakupoglu, C., Beck, H., Forster, H., Schmidt, J., Schmahl, W., Schweizer, U., Conrad, M., Brielmeier, M., The role of thioredoxin reductases in brain development. PLoS One, 3(3), 2008, e1813.
115. Conrad, M., Jakupoglu, C., Moreno, S.G., Lippl, S., Banjac, A., Schneider, M., Beck, H., Hatzopoulos, A.K., Just, U., Sinowatz, F., Schmahl, W., Chien, K.R., Wurst, W., Bornkamm, G.W., Brielmeier, M., Essential role for mitochondrial thioredoxin reductase in hematopoiesis, heart development, and heart function. Mol. Cell. Biol. 24:21 (2004), 9414–9423.
116. Kiermayer, C., Northrup, E., Schrewe, A., Walch, A., de Angelis, M.H., Schoensiegel, F., Zischka, H., Prehn, C., Adamski, J., Bekeredjian, R., Ivandic, B., Kupatt, C., Brielmeier, M., Heart-specific knockout of the mitochondrial thioredoxin reductase (Txnrd2) induces metabolic and contractile dysfunction in the aging myocardium. J. Am. Heart Assoc., 4(7), 2015.
117. Horstkotte, J., Perisic, T., Schneider, M., Lange, P., Schroeder, M., Kiermayer, C., Hinkel, R., Ziegler, T., Mandal, P.K., David, R., Schulz, S., Schmitt, S., Widder, J., Sinowatz, F., Becker, B.F., Bauersachs, J., Naebauer, M., Franz, W.M., Jeremias, I., Brielmeier, M., Zischka, H., Conrad, M., Kupatt, C., Mitochondrial thioredoxin reductase is essential for early postischemic myocardial protection. Circulation 124:25 (2011), 2892–2902.
118. Geisberger, R., Kiermayer, C., Homig, C., Conrad, M., Schmidt, J., Zimber-Strobl, U., Brielmeier, M., B- and T-cell-specific inactivation of thioredoxin reductase 2 does not impair lymphocyte development and maintenance. Biol. Chem. 388:10 (2007), 1083–1090.
119. Yan, J., Xu, J., Fei, Y., Jiang, C., Zhu, W., Han, Y., Lu, S., TrxR2 deficiencies promote chondrogenic differentiation and induce apoptosis of chondrocytes through mitochondrial reactive oxygen species. Exp. Cell Res. 344:1 (2016), 67–75.
120. Kirsch, J., Schneider, H., Pagel, J.I., Rehberg, M., Singer, M., Hellfritsch, J., Chillo, O., Schubert, K.M., Qiu, J., Pogoda, K., Kameritsch, P., Uhl, B., Pircher, J., Deindl, E., Muller, S., Kirchner, T., Pohl, U., Conrad, M., Beck, H., Endothelial dysfunction, and A prothrombotic, proinflammatory phenotype is caused by loss of mitochondrial thioredoxin reductase in endothelium. Arterioscler. Thromb. Vasc. Biol. 36:9 (2016), 1891–1899.
121. Hellfritsch, J., Kirsch, J., Schneider, M., Fluege, T., Wortmann, M., Frijhoff, J., Dagnell, M., Fey, T., Esposito, I., Kolle, P., Pogoda, K., Angeli, J.P., Ingold, I., Kuhlencordt, P., Ostman, A., Pohl, U., Conrad, M., Beck, H., Knockout of mitochondrial thioredoxin reductase stabilizes prolyl hydroxylase 2 and inhibits tumor growth and tumor-derived angiogenesis. Antioxid. Redox Signal. 22:11 (2015), 938–950.
122. Du, Y., Zhang, H., Zhang, X., Lu, J., Holmgren, A., Thioredoxin 1 is inactivated due to oxidation induced by peroxiredoxin under oxidative stress and reactivated by the glutaredoxin system. J. Biol. Chem. 288:45 (2013), 32241–32247.
123. Shen, X., Burguillos, M.A., Osman, A.M., Frijhoff, J., Carrillo-Jimenez, A., Kanatani, S., Augsten, M., Saidi, D., Rodhe, J., Kavanagh, E., Rongvaux, A., Rraklli, V., Nyman, U., Holmberg, J., Ostman, A., Flavell, R.A., Barragan, A., Venero, J.L., Blomgren, K., Joseph, B., Glioma-induced inhibition of caspase-3 in microglia promotes a tumor-supportive phenotype. Nat. Immunol. 17:11 (2016), 1282–1290.
124. Hashemy, S.I., Holmgren, A., Regulation of the catalytic activity and structure of human thioredoxin 1 via oxidation and S-nitrosylation of cysteine residues. J. Biol. Chem. 283:32 (2008), 21890–21898.
125. Benhar, M., Forrester, M.T., Hess, D.T., Stamler, J.S., Regulated protein denitrosylation by cytosolic and mitochondrial thioredoxins. Science 320:5879 (2008), 1050–1054.
126. Tannenbaum, S.R., White, F.M., Regulation and specificity of S-nitrosylation and denitrosylation. ACS Chem. Biol. 1:10 (2006), 615–618.
127. Wedmann, R., Onderka, C., Wei, S., Szijarto, I.A., Miljkovic, J.L., Mitrovic, A., Lange, M., Savitsky, S., Yadav, P.K., Torregrossa, R., Harrer, E.G., Harrer, T., Ishii, I., Gollasch, M., Wood, M.E., Galardon, E., Xian, M., Whiteman, M., Banerjee, R., Filipovic, M.R., Improved tag-switch method reveals that thioredoxin acts as depersulfidase and controls the intracellular levels of protein persulfidation. Chem. Sci. 7:5 (2016), 3414–3426.
128. Dagnell, M., Frijhoff, J., Pader, I., Augsten, M., Boivin, B., Xu, J., Mandal, P.K., Tonks, N.K., Hellberg, C., Conrad, M., Arnér, E.S.J., Östman, A., Selective activation of oxidized PTP1B by the thioredoxin system modulates PDGFβ-receptor tyrosine kinase signaling. Proc. Natl. Acad. Sci. USA 110 (2013), 13398–13403.
129. Schwertassek, U., Haque, A., Krishnan, N., Greiner, R., Weingarten, L., Dick, T.P., Tonks, N.K., Reactivation of oxidized PTP1B and PTEN by thioredoxin 1. FEBS J. 281:16 (2014), 3545–3558.
130. Salmeen, A., Andersen, J.N., Myers, M.P., Meng, T.C., Hinks, J.A., Tonks, N.K., Barford, D., Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate. Nature 423:6941 (2003), 769–773.
131. Lim, P.L., Liu, J., Go, M.L., Boelsterli, U.A., The mitochondrial superoxide/thioredoxin-2/Ask1 signaling pathway is critically involved in troglitazone-induced cell injury to human hepatocytes. Toxicol. Sci. 101:2 (2008), 341–349.
132. Tobiume, K., Matsuzawa, A., Takahashi, T., Nishitoh, H., Morita, K., Takeda, K., Minowa, O., Miyazono, K., Noda, T., Ichijo, H., ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep. 2 (2001), 222–228.
133. Saitoh, M., Nishitoh, H., Fujii, M., Takeda, K., Tobiume, K., Sawada, Y., Kawabata, M., Miyazono, K., Ichijo, H., Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 17 (1998), 2596–2606.
134. Abderrazak, A., Syrovets, T., Couchie, D., El Hadri, K., Friguet, B., Simmet, T., Rouis, M., NLRP3 inflammasome: from a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases. Redox Biol. 4 (2015), 296–307.
135. Kim, S.J., Lee, S.M., NLRP3 inflammasome activation in D-galactosamine and lipopolysaccharide-induced acute liver failure: role of heme oxygenase-1. Free Radic. Biol. Med. 65 (2013), 997–1004.
136. Zhou, R., Tardivel, A., Thorens, B., Choi, I., Tschopp, J., Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 11:2 (2010), 136–140.
137. Mannick, J.B., Schonhoff, C.M., Measurement of protein S-nitrosylation during cell signaling. Methods Enzymol. 440 (2008), 231–242.
138. Sun, J., Steenbergen, C., Murphy, E., S-nitrosylation: no-related redox signaling to protect against oxidative stress. Antioxid. Redox Signal. 8:9–10 (2006), 1693–1705.
139. Hess, D.T., Matsumoto, A., Kim, S.O., Marshall, H.E., Stamler, J.S., Protein S-nitrosylation: purview and parameters. Nat. Rev. Mol. Cell Biol. 6:2 (2005), 150–166.
140. Holmgren, A., Biochemistry. SNO removal. Science 320:5879 (2008), 1019–1020.
141. Mitchell, D.A., Morton, S.U., Fernhoff, N.B., Marletta, M.A., Thioredoxin is required for S-nitrosation of procaspase-3 and the inhibition of apoptosis in Jurkat cells. Proc. Natl. Acad. Sci. USA 104:28 (2007), 11609–11614.
142. Mitchell, D.A., Marletta, M.A., Thioredoxin catalyzes the S-nitrosation of the caspase-3 active site cysteine. Nat. Chem. Biol. 1:3 (2005), 154–158.
143. Stoyanovsky, D.A., Tyurina, Y.Y., Tyurin, V.A., Anand, D., Mandavia, D.N., Gius, D., Ivanova, J., Pitt, B., Billiar, T.R., Kagan, V.E., Thioredoxin and lipoic acid catalyze the denitrosation of low molecular weight and protein S-nitrosothiols. J. Am. Chem. Soc. 127:45 (2005), 15815–15823.
144. Arnér, E.S.J., Nordberg, J., Holmgren, A., Efficient reduction of lipoamide and lipoic acid by mammalian thioredoxin reductase. Biochem. Biophys. Res. Commun. 225 (1996), 268–274.
145. Sengupta, R., Ryter, S.W., Zuckerbraun, B.S., Tzeng, E., Billiar, T.R., Stoyanovsky, D.A., Thioredoxin catalyzes the denitrosation of low-molecular mass and protein S-nitrosothiols. Biochemistry 46:28 (2007), 8472–8483.
146. Nikitovic, D., Holmgren, A., S-nitrosoglutathione is cleaved by the thioredoxin system with liberation of glutathione and redox regulating nitric oxide. J. Biol. Chem. 271 (1996), 19180–19185.
147. Schulze, P.C., Liu, H., Choe, E., Yoshioka, J., Shalev, A., Bloch, K.D., Lee, R.T., Nitric oxide-dependent suppression of thioredoxin-interacting protein expression enhances thioredoxin activity. Arterioscler. Thromb. Vasc. Biol. 26:12 (2006), 2666–2672.
148. Benhar, M., Forrester, M.T., Stamler, J.S., Protein denitrosylation: enzymatic mechanisms and cellular functions. Nat. Rev. Mol. Cell Biol. 10:10 (2009), 721–732.
149. Katz, M., Amit, I., Yarden, Y., Regulation of MAPKs by growth factors and receptor tyrosine kinases. Biochim. Biophys. Acta 1773:8 (2007), 1161–1176.
150. Jiang, F., Zhang, Y., Dusting, G.J., NADPH oxidase-mediated redox signaling: roles in cellular stress response, stress tolerance, and tissue repair. Pharmacol. Rev. 63:1 (2011), 218–242.
151. Cho, S.H., Lee, C.H., Ahn, Y., Kim, H., Ahn, C.Y., Yang, K.S., Lee, S.R., Redox regulation of PTEN and protein tyrosine phosphatases in H(2)O(2) mediated cell signaling. FEBS Lett. 560:1–3 (2004), 7–13.
152. Finkel, T., Redox-dependent signal transduction. FEBS Lett. 476 (2000), 52–54.
153. Duncan, R.E., Ahmadian, M., Jaworski, K., Sarkadi-Nagy, E., Sul, H.S., Regulation of lipolysis in adipocytes. Annu. Rev. Nutr. 27 (2007), 79–101.
154. de Pina, M.Z., Vazquez-Meza, H., Pardo, J.P., Rendon, J.L., Villalobos-Molina, R., Riveros-Rosas, H., Pina, E., Signaling the signal, cyclic AMP-dependent protein kinase inhibition by insulin-formed H2O2 and reactivation by thioredoxin. J. Biol. Chem. 283:18 (2008), 12373–12386.
155. Molin, M., Yang, J., Hanzen, S., Toledano, M.B., Labarre, J., Nystrom, T., Life span extension and H(2)O(2) resistance elicited by caloric restriction require the peroxiredoxin Tsa1 in Saccharomyces cerevisiae. Mol. Cell 43:5 (2011), 823–833.
156. Gundimeda, U., Schiffman, J.E., Chhabra, D., Wong, J., Wu, A., Gopalakrishna, R., Locally generated methylseleninic acid induces specific inactivation of protein kinase C isoenzymes: relevance to selenium-induced apoptosis in prostate cancer cells. J. Biol. Chem., 2008.
157. Kahlos, K., Zhang, J., Block, E.R., Patel, J.M., Thioredoxin restores nitric oxide-induced inhibition of protein kinase C activity in lung endothelial cells. Mol. Cell Biochem. 254:1–2 (2003), 47–54.
158. Anema, S.M., Walker, S.W., Howie, A.F., Arthur, J.R., Nicol, F., Beckett, G.J., Thioredoxin reductase is the major selenoprotein expressed in human umbilical-vein endothelial cells and is regulated by protein kinase C. Biochem. J. 342 (1999), 111–117.
159. Kwon, J., Lee, S.R., Yang, K.S., Ahn, Y., Kim, Y.J., Stadtman, E.R., Rhee, S.G., Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors. Proc. Natl. Acad. Sci. USA 101:47 (2004), 16419–16424.
160. Lee, S.R., Yang, K.S., Kwon, J., Lee, C., Jeong, W., Rhee, S.G., Reversible inactivation of the tumor suppressor PTEN by H2O2. J. Biol. Chem. 277:23 (2002), 20336–20342.
161. Parsons, Z.D., Gates, K.S., Thiol-dependent recovery of catalytic activity from oxidized protein tyrosine phosphatases. Biochemistry 52:37 (2013), 6412–6423.
162. Dagnell, M., Pace, P.E., Cheng, Q., Frijhoff, J., Ostman, A., Arner, E.S.J., Hampton, M.B., Winterbourn, C.C., Thioredoxin reductase 1 and NADPH directly protect protein tyrosine phosphatase 1B from inactivation during H2O2 exposure. J. Biol. Chem. 292:35 (2017), 14371–14380.
163. Shinozaki, Y., Koizumi, S., Ohno, Y., Nagao, T., Inoue, K., Extracellular ATP counteracts the ERK1/2-mediated death-promoting signaling cascades in astrocytes. Glia 54:6 (2006), 606–618.
164. Sohn, J., Rudolph, J., Catalytic and chemical competence of regulation of cdc25 phosphatase by oxidation/reduction. Biochemistry 42:34 (2003), 10060–10070.
165. Marshall, C.J., Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:2 (1995), 179–185.
166. Liu, Y., He, C., A review of redox signaling and the control of MAP kinase pathway in plants. Redox Biol. 11 (2016), 192–204.
167. Latimer, H.R., Veal, E.A., Peroxiredoxins in regulation of MAPK signalling pathways; sensors and barriers to signal transduction. Mol. Cells 39:1 (2016), 40–45.
168. Ostman, A., Frijhoff, J., Sandin, A., Bohmer, F.D., Regulation of protein tyrosine phosphatases by reversible oxidation. J. Biochem. 150:4 (2011), 345–356.
169. Mihaylova, M.M., Shaw, R.J., The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat. Cell Biol. 13:9 (2011), 1016–1023.
170. Inoki, K., Kim, J., Guan, K.L., AMPK and mTOR in cellular energy homeostasis and drug targets. Annu. Rev. Pharmacol. Toxicol. 52 (2012), 381–400.
171. Xu, J., Ji, J., Yan, X.H., Cross-talk between AMPK and mTOR in regulating energy balance. Crit. Rev. Food Sci. Nutr. 52:5 (2012), 373–381.
172. Shao, D., Oka, S., Liu, T., Zhai, P., Ago, T., Sciarretta, S., Li, H., Sadoshima, J., A redox-dependent mechanism for regulation of AMPK activation by Thioredoxin1 during energy starvation. Cell Metab. 19:2 (2014), 232–245.
173. Oka, S.I., Hirata, T., Suzuki, W., Naito, D., Chen, Y., Chin, A., Yaginuma, H., Saito, T., Nagarajan, N., Zhai, P., Bhat, S., Schesing, K., Shao, D., Hirabayashi, Y., Yodoi, J., Sciarretta, S., Sadoshima, J., Thioredoxin-1 maintains mTOR function during oxidative stress in cardiomyocytes. J. Biol. Chem., 2017.
174. Ufer, C., Wang, C.C., Borchert, A., Heydeck, D., Kuhn, H., Redox control in mammalian embryo development. Antioxid. Redox Signal. 13:6 (2010), 833–875.
175. Ding, S., Li, C., Cheng, N., Cui, X., Xu, X., Zhou, G., Redox regulation in cancer stem cells. Oxid. Med. Cell. Longev., 2015, 2015, 750798.
176. Maillet, A., Pervaiz, S., Redox regulation of p53, redox effectors regulated by p53: a subtle balance. Antioxid. Redox Signal. 16:11 (2011), 1285–1294.
177. Cassidy, P.B., Edes, K., Nelson, C.C., Parsawar, K., Fitzpatrick, F.A., Moos, P.J., Thioredoxin reductase is required for the inactivation of tumor suppressor p53 and for apoptosis induced by endogenous electrophiles. Carcinogenesis 27:12 (2006), 2538–2549.
178. Moos, P.J., Edes, K., Cassidy, P., Massuda, E., Fitzpatrick, F.A., Electrophilic prostaglandins and lipid aldehydes repress redox-sensitive transcription factors p53 and hypoxia-inducible factor by impairing the selenoprotein thioredoxin reductase. J. Biol. Chem. 278:2 (2003), 745–750.
179. Hirota, K., Matsui, M., Iwata, S., Nishiyama, A., Mori, K., Yodoi, J., AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc. Natl. Acad. Sci. USA 94 (1997), 3633–3638.
180. Ueno, M., Masutani, H., Arai, R.J., Yamauchi, A., Hirota, K., Sakai, T., Inamoto, T., Yamaoka, Y., Yodoi, J., Nikaido, T., Thioredoxin-dependent redox regulation of p53-mediated p21 activation. J. Biol. Chem. 274 (1999), 35809–35815.
181. Funato, Y., Miki, H., Nucleoredoxin, a novel thioredoxin family member involved in cell growth and differentiation. Antioxid. Redox Signal. 9:8 (2007), 1035–1057.
182. Kurooka, H., Kato, K., Minoguchi, S., Takahashi, Y., Ikeda, J., Habu, S., Osawa, N., Buchberg, A.M., Moriwaki, K., Shisa, H., Honjo, T., Cloning and characterization of the nucleoredoxin gene that encodes a novel nuclear protein related to thioredoxin. Genomics 39 (1997), 331–339.
183. Mitsuishi, Y., Motohashi, H., Yamamoto, M., The Keap1-Nrf2 system in cancers: stress response and anabolic metabolism. Front. Oncol., 2, 2012, 200.
184. Higgins, L.G., Hayes, J.D., The cap'n’collar transcription factor Nrf2 mediates both intrinsic resistance to environmental stressors and an adaptive response elicited by chemopreventive agents that determines susceptibility to electrophilic xenobiotics. Chem. Biol. Interact. 192:1–2 (2011), 37–45.
185. Surh, Y.J., Kundu, J.K., Na, H.K., Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Med. 74:13 (2008), 1526–1539.
186. Osburn, W.O., Kensler, T.W., Nrf2 signaling: an adaptive response pathway for protection against environmental toxic insults. Mutat. Res. 659:1–2 (2008), 31–39.
187. Zhang, D.D., Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab. Rev. 38:4 (2006), 769–789.
188. Arner, E.S., Focus on mammalian thioredoxin reductases–important selenoproteins with versatile functions. Biochim. Biophys. Acta 1790:6 (2009), 495–526.
189. Hansen, J.M., Watson, W.H., Jones, D.P., Compartmentation of Nrf-2 redox control: regulation of cytoplasmic activation by glutathione and DNA binding by thioredoxin-1. Toxicol. Sci. : Off. J. Soc. Toxicol. 82:1 (2004), 308–317.
190. Cebula, M., Schmidt, E.E., Arner, E.S.J., TrxR1 as a potent regulator of the Nrf2-Keap1 response system. Antioxid. Redox Signal. 23:10 (2015), 823–853.
191. Hochmuth, C.E., Biteau, B., Bohmann, D., Jasper, H., Redox regulation by Keap1 and Nrf2 controls intestinal stem cell proliferation in drosophila. Cell stem Cell 8:2 (2011), 188–199.
192. Chio, I.I.C., Jafarnejad, S.M., Ponz-Sarvise, M., Park, Y., Rivera, K., Palm, W., Wilson, J., Sangar, V., Hao, Y., Ohlund, D., Wright, K., Filippini, D., Lee, E.J., Silva, B. Da, Schoepfer, C., Wilkinson, J.E., Buscaglia, J.M., DeNicola, G.M., Tiriac, H., Hammell, M., Crawford, H.C., Schmidt, E.E., Thompson, C.B., Pappin, D.J., Sonenberg, N., Tuveson, D.A., NRF2 promotes tumor maintenance by modulating mRNA translation in pancreatic cancer. Cell 166 (2016), 963–976.
193. Satoh, H., Moriguchi, T., Saigusa, D., Baird, L., Yu, L., Rokutan, H., Igarashi, K., Ebina, M., Shibata, T., Yamamoto, M., NRF2 intensifies host defense systems to prevent lung carcinogenesis, but after tumor initiation accelerates malignant cell growth. Cancer Res. 76:10 (2016), 3088–3096.
194. Ganan-Gomez, I., Wei, Y., Yang, H., Boyano-Adanez, M.C., Garcia-Manero, G., Oncogenic functions of the transcription factor Nrf2. Free Radic. Biol. Med. 65 (2013), 750–764.
195. Romero, R., Sayin, V.I., Davidson, S.M., Bauer, M.R., Singh, S.X., LeBoeuf, S.E., Karakousi, T.R., Ellis, D.C., Bhutkar, A., Sanchez-Rivera, F.J., Subbaraj, L., Martinez, B., Bronson, R.T., Prigge, J.R., Schmidt, E.E., Thomas, C.J., Goparaju, C., Davies, A., Dolgalev, I., Heguy, A., Allaj, V., Poirier, J.T., Moreira, A.L., Rudin, C.M., Pass, H.I., Vander Heiden, M.G., Jacks, T., Papagiannakopoulos, T., Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis. Nat. Med. 23:11 (2017), 1362–1368.
196. Gorrini, C., Gang, B.P., Bassi, C., Wakeham, A., Baniasadi, S.P., Hao, Z., Li, W.Y., Cescon, D.W., Li, Y.T., Molyneux, S., Penrod, N., Lupien, M., Schmidt, E.E., Stambolic, V., Gauthier, M.L., Mak, T.W., Estrogen controls the survival of BRCA1-deficient cells via a PI3K-NRF2-regulated pathway. Proc. Natl. Acad. Sci. USA 111:12 (2014), 4472–4477.
197. Wang, G.L., Semenza, G.L., Purification and characterization of hypoxia-inducible factor-1. J. Biol. Chem. 270:3 (1995), 1230–1237.
198. Greer, S.N., Metcalf, J.L., Wang, Y., Ohh, M., The updated biology of hypoxia-inducible factor. EMBO J. 31:11 (2012), 2448–2460.
199. Welsh, S.J., Bellamy, W.T., Briehl, M.M., Powis, G., The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis. Cancer Res. 62:17 (2002), 5089–5095.
200. Kim, W.J., Cho, H., Lee, S.W., Kim, Y.J., Kim, K.W., Antisense-thioredoxin inhibits angiogenesis via pVHL-mediated hypoxia-inducible factor-1alpha degradation. Int. J. Oncol. 26:4 (2005), 1049–1052.
201. Johansson, K., Cebula, M., Rengby, O., Dreij, K., Carlstrom, K.E., Sigmundsson, K., Piehl, F., Arner, E.S., Cross talk in HEK293 cells between Nrf2, HIF, and NF-kappaB activities upon challenges with redox therapeutics characterized with single-cell resolution. Antioxid. Redox Signal. 26:6 (2017), 229–246.
202. Hayden, M.S., Ghosh, S., NF-kappaB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev. 26:3 (2012), 203–234.
203. Hayden, M.S., Ghosh, S., Signaling to NF-kappaB. Genes Dev. 18:18 (2004), 2195–2224.
204. Myant, K.B., Cammareri, P., McGhee, E.J., Ridgway, R.A., Huels, D.J., Cordero, J.B., Schwitalla, S., Kalna, G., Ogg, E.L., Athineos, D., Timpson, P., Vidal, M., Murray, G.I., Greten, F.R., Anderson, K.I., Sansom, O.J., ROS production and NF-kappa B activation triggered by RAC1 facilitate WNT-driven intestinal stem cell proliferation and colorectal cancer initiation. Cell Stem Cell 12:6 (2013), 761–773.
205. Wu, X.L., Li, X., Li, Y., Kong, L.P., Fang, J.L., Zhou, X.S., Li, M., Jia, J.J., Bai, J., The overexpression of Thioredoxin-1 suppressing inflammation induced by methamphetamine in spleen. Drug Alcohol Depend. 159 (2016), 66–71.
206. Sakurai, A., Yuasa, K., Shoji, Y., Himeno, S., Tsujimoto, M., Kunimoto, M., Imura, N., Hara, S., Overexpression of thioredoxin reductase 1 regulates NF-kappa B activation. J. Cell. Physiol. 198:1 (2004), 22–30.
207. Sun, Y., Oberley, L.W., Redox regulation of transcriptional activators. Free Radic. Biol. Med. 21:3 (1996), 335–348.
208. Ma, X., Hu, J., Lindner, D.J., Kalvakolanu, D.V., Mutational analysis of human thioredoxin reductase 1. Effects on p53-mediated gene expression and interferon and retinoic acid-induced cell death. J. Biol. Chem. 277 (2002), 22460–22468.
209. Hu, J., Ma, X., Lindner, D.J., Karra, S., Hofmann, E.R., Reddy, S.P., Kalvakolanu, D.V., Modulation of p53 dependent gene expression and cell death through thioredoxin-thioredoxin reductase by the interferon-retinoid combination. Oncogene 20 (2001), 4235–4248.
210. Molchadsky, A., Rivlin, N., Brosh, R., Rotter, V., Sarig, R., p53 is balancing development, differentiation and de-differentiation to assure cancer prevention. Carcinogenesis 31:9 (2010), 1501–1508.
211. Fan, Y., Mao, R., Yang, J., NF-kappaB and STAT3 signaling pathways collaboratively link inflammation to cancer. Protein Cell 4:3 (2013), 176–185.
212. Zhang, Z., Wang, A., Li, H., Zhi, H., Lu, F., STAT3-dependent TXNDC17 expression mediates Taxol resistance through inducing autophagy in human colorectal cancer cells. Gene 584:1 (2016), 75–82.
213. Chong, C.R., Chan, W.P., Nguyen, T.H., Liu, S., Procter, N.E., Ngo, D.T., Sverdlov, A.L., Chirkov, Y.Y., Horowitz, J.D., Thioredoxin-interacting protein: pathophysiology and emerging pharmacotherapeutics in cardiovascular disease and diabetes. Cardiovasc. Drugs Ther. 28:4 (2014), 347–360.
214. Yoshihara, E., Masaki, S., Matsuo, Y., Chen, Z., Tian, H., Yodoi, J., Thioredoxin/Txnip: redoxisome, as a redox switch for the pathogenesis of diseases. Front. Immunol., 4, 2014, 514.
215. Spindel, O.N., World, C., Berk, B.C., Thioredoxin interacting protein: redox dependent and independent regulatory mechanisms. Antioxid. Redox Signal. 16:6 (2012), 587–596.
216. Xu, G., Chen, J., Jing, G., Shalev, A., Thioredoxin-interacting protein regulates insulin transcription through microRNA-204. Nat. Med. 19:9 (2013), 1141–1146.
217. Sobotta, M.C., Liou, W., Stocker, S., Talwar, D., Oehler, M., Ruppert, T., Scharf, A.N., Dick, T.P., Peroxiredoxin-2 and STAT3 form a redox relay for H2O2 signaling. Nat. Chem. Biol. 11:1 (2015), 64–70.
218. Sakurai, A., Nishimoto, M., Himeno, S., Imura, N., Tsujimoto, M., Kunimoto, M., Hara, S., Transcriptional regulation of thioredoxin reductase 1 expression by cadmium in vascular endothelial cells: role of NF-E2-related factor-2. J. Cell. Physiol. 203:3 (2005), 529–537.
219. Nalvarte, I., Damdimopoulos, A.E., Nystom, C., Nordman, T., Miranda-Vizuete, A., Olsson, J.M., Eriksson, L., Bjornstedt, M., Arner, E.S., Spyrou, G., Overexpression of enzymatically active human cytosolic and mitochondrial thioredoxin reductase in HEK-293 cells. Effect on cell growth and differentiation. J. Biol. Chem. 279:52 (2004), 54510–54517.
220. Patenaude, A., Ven Murthy, M.R., Mirault, M.E., Mitochondrial thioredoxin system: effects of TrxR2 overexpression on redox balance, cell growth, and apoptosis. J. Biol. Chem. 279:26 (2004), 27302–27314.
221. Chang, E.Y., Son, S.K., Ko, H.S., Baek, S.H., Kim, J.H., Kim, J.R., Induction of apoptosis by the overexpression of an alternative splicing variant of mitochondrial thioredoxin reductase. Free Radic. Biol. Med. 39:12 (2005), 1666–1675.